Featured Stories

Marking the first anniversary of the National Institute for Health and Care Excellence (NICE)’s final diagnostic guidance recommending two technologies for the remote monitoring of heart...

When David Stanley discovered he had kidney cancer, the news came on a day meant for celebration. Yet what followed was not a story of prolonged illness, but one of swift diagnosis and a rapid...

At Boston Scientific, we are working to confront climate change with a goal of achieving net-zero GHG emissions by 2050. In 2024, we made noteworthy progress by achieving 100% renewable electricity.

Benign prostatic hyperplasia (BPH) is a rapidly growing urological concern driven by a global aging population. With healthcare systems under strain due to increased demand, resource limitations,...

This year, TheraSphere™ Y-90 Glass Microspheres celebrates its 20th anniversary. Since its launch, TheraSphere has changed the way liver cancers are treated, helping more than 100,000 patients worldwide and over 30, 000 patients in the EMEA region.

Percutaneous cryoablation, a minimally invasive treatment which targets cancer cells with extreme cold via a needle, was as effective at treating a type of kidney cancer as removing tumours via a...

Across the healthcare sector, organisations are reassessing their environmental impact and seeking ways to reduce it. Boston Scientific believes that advancing science for life goes hand in hand...

According to a well-quoted statistic, women are less likely to apply for jobs than men unless they meet 100% of the qualifications, whilst men apply for a role if they meet 60% of the criteria.1...

Across Europe, patient organisations are finding new ways to be heard, not by speaking louder, but by working smarter. Boston Scientific Foundation Europe (BSFE) is seeing how digital tools are...

The National Institute for Health and Care Excellence (NICE), which provides evidence-based recommendations to improve health and social care in the National Health Service (NHS) in England and...